Cargando…
Androgen receptor as a mediator and biomarker of radioresistance in triple-negative breast cancer
Increased rates of locoregional recurrence have been observed in triple-negative breast cancer despite chemotherapy and radiation therapy. Thus, approaches that combine therapies for radiosensitization in triple-negative breast cancer are critically needed. We characterized the radiation therapy res...
Autores principales: | Speers, Corey, Zhao, Shuang G., Chandler, Ben, Liu, Meilan, Wilder-Romans, Kari, Olsen, Eric, Nyati, Shyam, Ritter, Cassandra, Alluri, Prasanna G., Kothari, Vishal, Hayes, Daniel F., Lawrence, Theodore S., Spratt, Daniel E., Wahl, Daniel R., Pierce, Lori J., Feng, Felix Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562815/ https://www.ncbi.nlm.nih.gov/pubmed/28840192 http://dx.doi.org/10.1038/s41523-017-0038-2 |
Ejemplares similares
-
Seviteronel, a Novel CYP17 Lyase Inhibitor and Androgen Receptor Antagonist, Radiosensitizes AR-Positive Triple Negative Breast Cancer Cells
por: Michmerhuizen, Anna R., et al.
Publicado: (2020) -
ARe we there yet? Understanding androgen receptor signaling in breast cancer
por: Michmerhuizen, Anna R., et al.
Publicado: (2020) -
Development and Validation of a Novel Platform-Independent Metastasis Signature in Human Breast Cancer
por: Zhao, Shuang G., et al.
Publicado: (2015) -
Bcl-xL Inhibition Radiosensitizes PIK3CA/PTEN Wild-type Triple-negative Breast Cancers with Low Mcl-1 Expression
por: Pesch, Andrea M., et al.
Publicado: (2022) -
Androgen and oestrogen receptor co-expression determines the efficacy of hormone receptor-mediated radiosensitisation in breast cancer
por: Michmerhuizen, Anna R., et al.
Publicado: (2022)